Les meilleurs doctors traitant la maladie suivante : Thrombocytopénie - TOP -46 des médecins

Dr. Ilia Kirshner is a hematologic oncologist with expertise in blood disorders, brain tumors, and prostate cancer. He is a Clinical Assistant Professor of Medicine at The Icahn School of Medicine at Mount Sinai.

Dr. Kirshner has led and contributed to important clinical trials. He was involved in a phase III study on enzalutamide for castrate-resistant prostate cancer. He completed fellowships in hematology (1995) and medical oncology (1994) at Montefiore Medical Center. He also finished his internal medicine residency at St. Luke’s-Roosevelt Hospital Center in 1990.

Le professeur Drach est spécialiste en oncologie et titulaire d'un doctorat de l'université médicale de Vienne. Il a de l'expérience dans les domaines de la recherche, de la médecine interne, de l'oncologie hématologique, de la nutrition et du mode de vie dans le cancer. Il est directeur de la clinique privée Josefstadt à Vienne et membre du conseil d'administration de la Société autrichienne d'hématologie et d'oncologie. Il a publié plus de 120 articles scientifiques et donné plus de 200 conférences/présentations.

Dr. Viola Fox is the Chief Physician at the Clinic for Haematology, Oncology, and Palliative Medicine at BKZ Solingen. This clinic is a certified interdisciplinary cancer center. Dr. Fox is a leading expert in drug therapy for tumor diseases in Germany and Europe. She has more than 15 years of experience in this field.

She is a member of the German Society of Oncology and Haemato-oncology (GDHO), the German Association of Physicians, and the American Association for Cancer Research. Dr. Fox is also active in molecular biology research. Her work supports progress in cancer treatment and molecular diagnostics.

Her main areas of expertise are chemotherapy, immunotherapy, targeted therapy, and radiation therapy. Dr. Fox is known for her innovative methods and strong commitment to patient care. Her efforts have led to high recovery rates and recognition from her peers.

Éducation et spécialisation

• 2006 : Faculté de médecine de l'Université de Kocaeli
• 2014 : Faculté de médecine de l'Université d'Akdeniz, Médecine interne
• 2018 : Faculté de médecine de l'Université d'Akdeniz, Oncologie médicale

Expérience

• 2006 - 2008 : Hôpital du district de Konya Derebucak
• 2009 - 2015 : Hôpital universitaire d'Akdeniz
• 2015 : Hôpital d'État d'Antalya Kaş
• 2015 - 2016 : Faculté de médecine de l'Université d'İnönü
• 2016 - 2021 : Hôpital universitaire d'Akdeniz
• 2021 - 2023 : Hôpital de formation et de recherche d'Antalya

Prof. Dr. Ceyhun Bozkurt is a respected Pediatric Hematologist-Oncologist. He is known for his work in childhood blood disorders and cancers. He graduated from Cerrahpaşa Faculty of Medicine. He holds specializations in both Pediatrics and Pediatric Oncology. Since 2019, he has been Professor and Clinical Director at Bahçelievler Medical Park Hospital. He also serves as Vice Director of the Stem Cell Transplant Unit.

Dr. Bozkurt has published over 40 peer-reviewed articles. He is recognized for his work in leukemia, bone marrow transplantation, and stem cell therapy. He is a member of organizations such as SIOP and EBMT. His memberships show his dedication to high standards in clinical care and research.

Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.

Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical bone marrow transplantation. He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.

Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.

Dr. Francesc Bosch is an expert in Chronic Lymphocytic Leukemia (CLL) and lymphomas. He leads research in the molecular causes and new treatments for CLL and other lymphoproliferative disorders.

He has published over 100 articles in leading journals, including The New England Journal of Medicine and Nature Medicine. Dr. Bosch oversees more than 80 clinical studies, from phase 1 to phase 3, and plays a key role in developing new drugs.

He is the Head of Hematology at Vall d’Hebron University Hospital and IOB Institute of Oncology. He also serves as president of GELLC and is a professor of hematology. His work has improved diagnosis and treatment for blood diseases.

Prof. Dr. Serdar Bedii Omay is a respected hematologist. He specializes in Hematology and Bone Marrow Transplantation. He graduated from Hacettepe Medical School in 1985. He completed his Internal Medicine training at Ege University in 1990. He earned his PhD in Hematology at Japan Mie Medical School in 1995.

Dr. Omay has published 65 scientific articles, 112 meeting papers, and 34 international conference presentations. He has served as a professor at Ege University and Karadeniz Technical University. He also worked as a Hematology Specialist and Molecular Hematology Doctor in Japan. His career shows strong expertise and international recognition in his field.

Prof. Dr. Birol Baytan is a respected pediatric hematologist. He focuses on diagnosing and treating childhood cancers, leukemia, anemia, and bleeding disorders. He graduated from Ankara University Medical Faculty in 1992. He completed his specialization at Uludağ University Faculty of Medicine, Department of Child Diseases.

Prof. Baytan has published 15 articles in international journals. He has presented and published 9 full texts at international scientific meetings. He has contributed to 3 books or book chapters. He has also published 8 articles in local journals. These achievements show his strong academic presence in pediatric hematology.

Domaines d'intérêt

1. Greffe de moelle osseuse
2. Leucémie
3. Lymphome
4. Myélome multiple
5. Thalassémie
6. Maladies de la moelle osseuse
7. Plasmaphérèse

Éducation
2005 Diplômé de l'Université Hacettepe, Faculté de Médecine
2010 Université Hacettepe, Faculté de médecine Spécialiste en médecine interne
2014 Université d'Ankara, Faculté de médecine Spécialiste en hématologie

Expérience
Octobre 2010 - Décembre 2010 Spécialiste en médecine interne à l'hôpital d'oncologie d'Ankara
Décembre 2010 - Avril 2011 Assistante de la sous-branche d'hématologie à l'hôpital d'oncologie d'Ankara
Septembre 2014 - mai 2016 Spécialiste en hématologie à l'hôpital de formation et de recherche de l'Université Kütahya Dumlupınar Evliya Çelebi
Mai 2016 - mars 2018 Université d'Ufuk, Faculté de médecine, Département d'hématologie Membre du corps professoral
Mars 2018 - octobre 2018 Université Hitit, Faculté de médecine, Département d'hématologie Membre du corps professoral
Novembre 2018 - Janvier 2019 Médecin de l'unité d'hématologie et de transplantation de moelle osseuse du Medical Park Bahçelievler
Février 2019 - Juin 2022 Présent Hôpital Bayındır Söğütözü Unité d'hématologie et de transplantation de cellules souches, médecin adjoint responsable
Juin 2022 - Juillet 2022 Université des sciences de la santé d'Afyonkarahisar, Chef du département d'hématologie

Certificats de qualification
Certificat de qualification du Conseil de médecine interne, 2009
Certificat de qualification du conseil d'hématologie, 2014
Maîtrise de l'anglais 2017/7 Score e-YDS : 71,25
Thèse de spécialisation en médecine interne Ajout de trastuzumab de 9 semaines au traitement adjuvant chez les patientes atteintes d'un cancer du sein positif Analyse rétrospective

Éducation à l'étranger
Entre octobre et décembre 2007 (3 mois) Enseignement en soins intensifs à l'Université de Floride, États-Unis
Entre décembre 2013 et janvier 2014 (2 mois) Enseignement de la cytométrie de flux à l'Université de Salamanque, Espagne

Cours, récompenses et certificats
Certificat d'un an de travail en transplantation de moelle osseuse, 2017
Certificat en banque de sang et médecine transfusionnelle 2017
Prix du « Médecin de l’année » à Kütahya, 2014
Certificats GMP, GLP, ISO/IEC 17025: 2012, 2014
Certificat de bonnes pratiques cliniques, 2013
Şeref Zileli, Prix de l'assistante de l'année 2009
Certificat RIA, 2005

Recherche et publications

Brevet
1. Demi-anticorps dont la partie fc a été retirée (fab) à usage médical. Inventeur : Mehmet Özen. N° : 2016/0910. Brevet en cours d'examen.

Études scientifiques
A. Publications dans des revues internationales sous SCI Expanded


Section livres turcs

1. Ozen M, Konuk N. Purpura thrombocytopénique immunitaire. Turkoz Sucak G, rédacteur en chef. Sujets d'actualité en immunohématologie. 1ère édition. Ankara : Cliniques de Turquie ; 2021. p.8-12.

2. Özen M, Ural AU. Maladies hématologiques et applications des cellules souches mésenchymateuses. Türköz Sucak G, éditeur. Sujets d'actualité en immunohématologie. 1ère édition. Ankara : Cliniques de Turquie ; 2021. p.91-4.

3. Ozen M. Hématopoïèse et facteurs de croissance hématopoïétiques. MediHealth et Hippocrates MALADIES INTERNES avec les directives actuelles 2022. p1607-10

Dr. Girish V. Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He has over 13 years of clinical experience. He treats leukemia, multiple myeloma, and performs bone marrow transplants. Dr. Badarkhe has managed many complex cases with strong results.

He earned his MBBS from Grant Medical College. He completed his MD in Pathology at Lokmanya Tilak Municipal Medical College and his DM in Clinical Hematology at Medical College, Calcutta. Dr. Badarkhe has received several awards for his work and dedication in hematology-oncology.

Dr. Siret Ratip is a hematologist and oncologist with over 25 years of clinical experience. He focuses on internal medicine and hematology. He has worked as an associate professor at respected institutions, including University College Hospital in London.

Dr. Ratip is a member of the British Hematology Committee and the Hematology Federation of Turkey. He has performed many advanced procedures, such as autologous and allogenic bone marrow transplantation, bone marrow aspiration, and biopsy. He has made important contributions to patient care and research in thalassemia.

Prof. Dr. Songul Serefhanoglu is a leading hematologist. She is the Director and President of the Adult Hematology Department at Sisli Memorial Hospital in Istanbul, a role she has held since 2019. She also practices at ISU Medical Park. Dr. Serefhanoglu specializes in peripheral hematopoietic stem cell transplantation. Each year, she performs 100-120 transplants, including 60-70 allogenic and 40-50 autologous procedures.

Dr. Serefhanoglu earned her medical degree from Firat University. She completed her residency in Internal Medicine at Inonu University and her hematology training at Hacettepe University. She became an Associate Professor in 2012 and a full Professor in 2018. Dr. Serefhanoglu has held leadership positions in several major hospitals in Istanbul, demonstrating her expertise in hematology.

Dr. Yener Koç is a bone marrow transplant specialist trained in the USA. He founded the Bone Marrow Transplant Center at Medicana International Istanbul. Dr. Koç has performed more than 1,900 transplants. His patients have long-term survival rates of 66-90% for different blood disorders. He keeps mortality rates low, between 0.5-9%.

Dr. Koç has written over 230 scientific articles. Since 2004, he has served as a JACIE Accreditation Inspector for European Bone Marrow Transplant Centers. He has received several awards, including the Outstanding Physician Award from Boston University and the International Healthcare Professional of the Year (UK).